Riskpilot← Back to searchSign inGet full accessJACOMEDIC AS
ASActiveOrg 986938230Dalstuvegen 18, 2340 LøtenWholesale of pharmaceutical and medical goods · NACE 4646Est. 20041 employeeswww.jacomedic.no
Revenue 2022
NOK 37,2M
+15% vs 2021
EBITDA margin
17.2%
-3% vs 2021
Equity ratio
9.3%
Financial strength
Net profit 2022
NOK 4,9M
-3% vs 2021
| Revenue | NOK 37,2M | +15% |
| EBITDA | NOK 6,4M | -3% |
| Net profit | NOK 4,9M | -3% |
| Total assets | NOK 21M | +11% |
| Equity | NOK 1,9M | -80% |
| Employees | 1 | — |
Legal name
JACOMEDIC AS
Org number
986938230
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
12. juni 2004
Share capital
NOK 700 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Styrets leder og daglig leder hver for seg.
Company purpose
Handel, service, rådgivning, import- og agenturvirksomhet og alt som står i naturlig forbindelse med dette samt deltagelse i andre selskaper og virksomheter med tilsvarende formål, samt kjøp og salg av fast eiendom.
Address
Dalstuvegen 18, 2340 Løten
Phone
+4769262900
Email
post@jacomedic.no
Website
www.jacomedic.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 9 738 | 10 678 | 9 806 | 10 920 | 11 923 | 13 982 | 16 076 | 19 050 | 19 344 | 23 428 | 24 742 | 27 783 | 44 755 | 32 444 | 37 151 |
| Staff expenses | −0 | −2 237 | −2 199 | −2 443 | −2 940 | −2 905 | −3 582 | −4 124 | −4 362 | −4 235 | −4 528 | −5 135 | −0 | −6 436 | −5 238 | −7 059 |
| EBITDA | 0 | −506 | 250 | −1 569 | −195 | 580 | 223 | 370 | 1 803 | 2 404 | 3 312 | 3 285 | 3 328 | 10 854 | 6 568 | 6 392 |
| Depreciation & amort. | −0 | −3 | −50 | −17 | −12 | −25 | −259 | −362 | −309 | −207 | −114 | −224 | −304 | −183 | −161 | −149 |
| EBIT | 0 | −509 | 200 | −1 586 | −207 | 555 | −36 | 8 | 1 494 | 2 197 | 3 198 | 3 061 | 3 024 | 10 672 | 6 407 | 6 243 |
| Net financials | 0 | −57 | −67 | −80 | −163 | −161 | −208 | −234 | −164 | −101 | −3 | −21 | −27 | −66 | −0 | −2 |
| Profit before tax | 0 | −565 | 133 | −1 667 | −370 | 395 | −244 | −226 | 1 330 | 2 095 | 3 195 | 3 040 | 2 997 | 10 606 | 6 407 | 6 241 |
| Tax | −0 | −151 | 40 | −461 | −100 | 113 | −43 | −59 | 385 | 527 | 525 | 704 | 662 | 2 339 | 1 413 | 1 379 |
| Net profit | 0 | −414 | 93 | −1 205 | −269 | 282 | −201 | −167 | 945 | 1 568 | 2 670 | 2 336 | 2 335 | 8 267 | 4 994 | 4 862 |
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | — | 4 463 | 4 586 | 3 782 | 4 212 | 4 559 | 6 065 | 6 609 | 6 165 | 6 162 | 8 663 | 10 704 | 11 639 | 19 934 | 18 893 | 21 007 |
| Equity | — | 2 004 | 2 097 | 1 326 | 1 056 | 1 338 | 1 137 | 970 | 1 315 | 2 883 | 2 855 | 3 691 | 4 326 | 7 593 | 9 587 | 1 949 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 630 | 1 309 | 1 719 | 920 | 552 | 0 | 825 | 780 | 31 | 30 | 29 |
| Short-term debt | 0 | 2 255 | 1 977 | 2 407 | 2 656 | 2 591 | 3 620 | 3 920 | 3 930 | 2 726 | 5 808 | 6 188 | 6 533 | 12 310 | 9 275 | 19 030 |
| Total debt | 0 | 2 459 | 2 489 | 2 456 | 3 156 | 3 221 | 4 929 | 5 639 | 4 850 | 3 279 | 5 808 | 7 013 | 7 313 | 12 341 | 9 306 | 19 058 |
EBITDA margin
17.2%
This company
15.8%
Market median
+9% vs market
20072022
Equity ratio
9.3%
This company
38.2%
Market median
-76% vs market
20072022
Return on equity
249.5%
This company
18.4%
Market median
+1256% vs market
20072022
Net profit margin
13.1%
This company
8.1%
Market median
+62% vs market
20072022
Asset turnover
1.77×
This company
1.12×
Market median
+58% vs market
20072022
Debt / equity
9.78×
This company
0.62×
Market median
-1477% vs market
20072022
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
- Annual report 2007Filed via Brønnøysundsregistrene · Period 2007-01-01 – 2007-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HR Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
PE Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2023 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 30.0% | 30.0% | 2022 | |
Victoria Concordia Crescit As | Company | 10.0% | 10.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Victoria Concordia Crescit As
JACOMEDIC AS Board members of JACOMEDIC AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henrik Rustad | Chief Executive Officer | 0 companies |
| Petter Ek Jacobsen | Chief Executive Officer | 0 companies |
| Thomas Nortvedt | Board of Directors | 0 companies |
| Linn-Marie Bratterud Enger | Board of Directors | 0 companies |
| Solveig Henriette Alsvik | Board of Directors | 0 companies |
| Knut Egil Østerlie Hansen | Chairman | 0 companies |
| Morten Rindal Øvsteng | Board of Directors | 0 companies |
| Lars Erik Stensvehagen | Board of Directors | 0 companies |